A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
- DOI
- 10.1158/1535-7163.mct-25-0985
- Published
- 2026-03-17
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-25-0985,
title = {A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells},
author = {Laura G. Volta and Celeste Gobbi and Christian Koch and Niclas Harrer and Mara Hofstetter and Monique Maurer and Florin Schneiter and Francesco Manfredi and Christian Pellegrino and Chiara F. Magnani and Timm Schroeder and Dario Neri and Markus G. Manz},
year = {2026},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-25-0985},
url = {https://doi.org/10.1158/1535-7163.mct-25-0985}
}RIS
TY - JOUR TI - A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells AU - Laura G. Volta AU - Celeste Gobbi AU - Christian Koch AU - Niclas Harrer AU - Mara Hofstetter AU - Monique Maurer AU - Florin Schneiter AU - Francesco Manfredi AU - Christian Pellegrino AU - Chiara F. Magnani AU - Timm Schroeder AU - Dario Neri AU - Markus G. Manz PY - 2026 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-25-0985 UR - https://doi.org/10.1158/1535-7163.mct-25-0985 ER -
APA
Volta, L. G., Gobbi, C., Koch, C., Harrer, N., Hofstetter, M., Maurer, M., Schneiter, F., Manfredi, F., Pellegrino, C., Magnani, C. F., Schroeder, T., Neri, D., & Manz, M. G. (2026). A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-25-0985
Source records
- crossref · retrieved 2026-09-26T19:00:56.524Z